» Articles » PMID: 18545691

Heparanase Facilitates Cell Adhesion and Spreading by Clustering of Cell Surface Heparan Sulfate Proteoglycans

Overview
Journal PLoS One
Date 2008 Jun 12
PMID 18545691
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Heparanase is a heparan sulfate (HS) degrading endoglycosidase participating in extracellular matrix degradation and remodeling. Apart of its well characterized enzymatic activity, heparanase was noted to exert also enzymatic-independent functions. Non-enzymatic activities of heparanase include enhanced adhesion of tumor-derived cells and primary T-cells. Attempting to identify functional domains of heparanase that would serve as targets for drug development, we have identified heparin binding domains of heparanase. A corresponding peptide (residues Lys(158)-Asp(171), termed KKDC) was demonstrated to physically associate with heparin and HS, and to inhibit heparanase enzymatic activity. We hypothesized that the pro-adhesive properties of heparanase are mediated by its interaction with cell surface HS proteoglycans, and utilized the KKDC peptide to examine this possibility. We provide evidence that the KKDC peptide interacts with cell membrane HS, resulting in clustering of syndecan-1 and syndecan-4. We applied classical analysis of cell morphology, fluorescent and time-lapse microscopy and demonstrated that the KKDC peptide efficiently stimulates the adhesion and spreading of various cell types, mediated by PKC, Src, and the small GTPase Rac1. These results support, and further substantiate the notion that heparanase function is not limited to its enzymatic activity.

Citing Articles

Regulatory T cells use heparanase to access IL-2 bound to extracellular matrix in inflamed tissue.

Martinez H, Koliesnik I, Kaber G, Reid J, Nagy N, Barlow G Nat Commun. 2024; 15(1):1564.

PMID: 38378682 PMC: 10879116. DOI: 10.1038/s41467-024-45012-9.


Heparanase-A single protein with multiple enzymatic and nonenzymatic functions.

Vlodavsky I, Kayal Y, Hilwi M, Soboh S, Sanderson R, Ilan N Proteoglycan Res. 2023; 1(3):e6.

PMID: 37547889 PMC: 10398610. DOI: 10.1002/pgr2.6.


Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis.

Nguyen T, Paone S, Chan E, Poon I, Baxter A, Thomas S Cells. 2022; 11(20).

PMID: 36291066 PMC: 9599978. DOI: 10.3390/cells11203198.


Non-enzymatic heparanase enhances gastric tumor proliferation via TFEB-dependent autophagy.

Yang M, Tang B, Wang S, Tang L, Wen D, Vlodavsky I Oncogenesis. 2022; 11(1):49.

PMID: 35970822 PMC: 9378687. DOI: 10.1038/s41389-022-00424-4.


Sulfated Hyaluronan Binds to Heparanase and Blocks Its Enzymatic and Cellular Actions in Carcinoma Cells.

Shi J, Kanoya R, Tani Y, Ishikawa S, Maeda R, Suzuki S Int J Mol Sci. 2022; 23(9).

PMID: 35563446 PMC: 9102160. DOI: 10.3390/ijms23095055.


References
1.
Barkalow F, Schwarzbauer J . Localization of the major heparin-binding site in fibronectin. J Biol Chem. 1991; 266(12):7812-8. View

2.
Woods A, McCarthy J, Furcht L, Couchman J . A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation. Mol Biol Cell. 1993; 4(6):605-13. PMC: 300967. DOI: 10.1091/mbc.4.6.605. View

3.
Sasisekharan R, Shriver Z, Venkataraman G, Narayanasami U . Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer. 2002; 2(7):521-8. DOI: 10.1038/nrc842. View

4.
Kramer M, Schirrmacher V, Fuks Z, Vlodavsky I . Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells. Int J Cancer. 1985; 35(4):483-91. DOI: 10.1002/ijc.2910350411. View

5.
Beauvais D, Rapraeger A . Syndecans in tumor cell adhesion and signaling. Reprod Biol Endocrinol. 2004; 2:3. PMC: 320497. DOI: 10.1186/1477-7827-2-3. View